Llwytho...

Thromboprophylaxis with dabigatran etexilate in patients over seventy-five years of age with moderate renal impairment undergoing or knee replacement

PURPOSE: Prospective, double-blind studies in orthopaedic patients have been conducted using the direct thrombin inhibitor dabigatran etexilate (hereafter referred to as dabigatran), with two doses investigated and approved for adults (220 mg and 150 mg once daily) to prevent venous thromboembolism...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Prif Awduron: Dahl, Ola E., Kurth, Andreas A., Rosencher, Nadia, Noack, Herbert, Clemens, Andreas, Eriksson, Bengt I.
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: Springer-Verlag 2011
Pynciau:
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC3311818/
https://ncbi.nlm.nih.gov/pubmed/22095136
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s00264-011-1393-5
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!